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Abstract: The present study examined the preparation of chitosan-silver 
nanocomposite films as carriers for silver release pattern. Chitosan a biopolymer 
having immense structural possibilities for chemical and mechanical modifications 
to generate novel properties, functions and applications. Chitosan–silver 
nanocomposite films has been synthesised by reduction method, which is a simple 
and inexpensive method. The chitosan-silver nanocomposite films was 
characterized in terms of its surface plasmon resonance and crystalline structure by 
using UV-Visible spectroscopy, X-ray diffraction, Fourier transform infrared and 
Scanning electron microscope. Swelling and release studies were carried out on 
crosslinked and un-crosslinked nanocomposite films. Antibacterial activities of 
chitosan-silver nanocomposite films were investigated on some pathogens: 
Staphylococcus aureus, Shigella dysenteriae, Escherichia coli, Salmonella typhii 
and Klebsiella pneumonia using agar well diffusion method. crosslinked chitosan-
silver nanocomposite demonstrated a slower release pattern relative to un-
crosslinked chitosan-silver nanocomposite. The crosslinked and un-crosslinked 
nanocomposite became dislodged and completely released at 120 minutes and 90 
minutes respectively. The results of the antibacterial activities revealed that the 
cross-linked chitosan-silver nanocomposite films has higher antibacterial 
properties than un-crosslinked chitosan-silver nanocomposite films. This study 
provides nanocomposite films potentially useful for delivery system.  
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1. Introduction 
In the past years, several synthetic as 
well as natural polymers have been 
examined for pharmaceutical 
applications. A basic requirement for 
these polymers to be used in humans or 
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animals is that they have to degrade into 
molecules with no toxicity to biological 
environments. In recent years, 
biodegradable polymers have attracted 
attention of researchers as carriers for 
drug delivery system [8]. 
 
Chitosan is a polysaccharide that occurs 
naturally. Its units are composed of 
randomly distributed β-(1-4)-linked D-
glucosamine (deacetylated unit) and N-
acetyl-D-glucosamine (acetylated unit). 
Chitosan interact very easily with 
bacterium and binds to DNA, 
glycosaminoglycans and most of the 
proteins, thereby enhancing the 
antimicrobial effect of metal 
nanoparticles [7]. Chitosan properties 
allow it to rapidly clot blood and have 
recently gained approval in the United 
State of America for use in bandages 
and other hemostatic products. Chitosan 
is used in pharmaceutical manufacturing 
as fillers in tablets and to mask bitter 
tastes in solutions taken by mouth. 
Films and coatings based on 
biopolymers functions as barriers 
against moisture, oxygen, aroma flavor 
as well as oil are the materials for future 
applications [3]. 
 
Metal nanoparticles embedded into 
polymer matrix can be used as sensor, 
materials with solvent switchable 
electronics properties, optical limiters 
and filters, and for optical data storage. 
They can be applied for catalytic 
applications and antimicrobial coatings. 
Nanocomposite of polymer/metal 
nanoparticles has attracted great 
attention because of its potential 
applications in the field of catalysis, 
bioengineering, photonics, and 
electronics [9]. Polymers are considered 
good host materials for metallic 
nanoparticles as well as other stabilizing 
agents, including citrates, organic 
solvents, and organometallics [4]. Some 
examples of metal/polymer 
nanocomposites being synthesized 
include poly (vinylalcohol), poly 
(vinylpyrolidone) [6], chitosan [1], 
gelatin [6]. This accounts for the 
different properties of nanocomposites 




All reagents in this work were of 
analytical grade and were used as 
received without further purification. 
AgNO3 (99.98% Sigma -Aldrich) was 
used as the silver precursor, Sodium 
citrate, (crosslinking agent), Ammonia 
solution, Sodium hydroxide and glacial 
acetic acid (99%) were also obtained 
from Sigma–Aldrich. All the aqueous 




2.2.1. Preparation of Crosslinked 
Chitosan-Silver Nanocomposite Films  
5 g of silver nitrate was dissolved by 
stirring in 100 mL of distilled water. 20 
mL of the solution was taken and 
aqueous NaOH was added dropwise to 
the vigorously stirred solution till 
precipitation occurred. The dirty green 
precipitate formed was dissolved in few 
drops of dilute ammonia. Two layers 
were formed after centrifugation and 
addition of acetic acid. It was decanted 
and added in chitosan matrix (6 mL, 1% 
(w/v) in acetic acid). Film was made by 
casting the solution on the petri dish and 
dried at room temperature for 24 hours. 
When the film has been harvested cross-
linking was done by dipping the film in 
a 10 mL solution of sodium citrate (5 % 
w/v) after adjustment to pH 5. The film 
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was washed with water to remove 
excess sodium citrate. 
 
2.2.2. Swelling Studies 
 The completely dried, pre-weighed 
chitosan, crosslinked chitosan-silver and 
un-crosslinked chitosan-silver 
nanocomposite films were immersed in 
250 mL phosphate buffer (pH 7.4) at 25 
oC. The water uptake of the films was 
measured at 20 minutes interval using 
analytical balance to determine the 
mass. The swelling ratio (Q) of the films 
was calculated using the following 
equation: Q = Ws/Wd,  
Where Ws is the weight of the swollen 
film at different time intervals (20, 40, 
60, 80, 100, 120 and 140 minutes) and 
Wd is the weight of dry film. 
 
2.2.3. Release Study 
In Vitro release study of silver from 
chitosan-silver nanocomposite films was 
determined. A known weight of the 
dried nanocomposite films was put in 
the 20 mL phosphate buffer solution in a 
50 mL tube. The temperature and 
rotation were adjusted to 37 oC and 90 
rpm respectively. At predetermined time 
of 30, 60, 90, 120, 150, 180 and 210 
minutes, 10 mL of sample was 
withdrawn and ultra-centrifuged for 30 
minutes. The samples were further 
analyzed using UV-Visible 
spectrophotometer. The absorbance of 
each solution of the nanocomposite 
films was measured at λmax 425 nm. 
 
2.2.4. Antibacterial activity of 
Chitosan-silver nanocomposite films 
The antimicrobial activities of the 
synthesized films were tested against 
human pathogens like Staphylococcus 
aureus, Shigella dysenteriae, 
Escherichia coli, Salmonella typhii and 
Klebsiella pnueumoniae by agar well 
diffusion method. An overnight culture 
of each pathogen grown in nutrient 
broth at 37 oC was diluted to a turbidity 
equivalent of 3.0×108 cfu/mL (1.0 
Mcfarland standard) with a sterile 
normal saline. The cell suspension was 
then swabbed on the surface of Mueller-
Hinton agar plates. A sterile cork borer 
of diameter 7 mm was used to make 
wells on the agar plates. Each well was 
filled with 50.0 µL of each solution of 
chitosan-silver nanocomposite. The 
plates were left for one hour to allow the 
test materials to diffuse in the agar and 
then incubated at 37 oC for 24 hours 
without inversion. The antimicrobial 
activity was determined by measuring 
the clear zone (zone of inhibition) 
around the wells. The diameter (mm) of 
the zone of inhibition of 1.00 mm or 
greater was considered as a significant 
inhibition [11]. 
 
2.3. Characterization Methods and 
Instruments 
The synthesized chitosan-silver 
nanocomposite films were confirmed 
using UV-visible spectroscopy (UV-
visible), X-ray diffraction (XRD), 
Scanning electron microscope (SEM) 
and Fourier transform infrared 
spectroscopy (FTIR). The UV-
visiblespectra of the nanocomposite 
were detected over the range of 300–700 
nm using a Shimadzu (UV.1650) UV-
visible spectrophotometer. Crystalline 
structures of the synthesized chitosan-
silver were examined using Rigaku 
D/Max-2550Pc (Tokyo. Japan). 
Morphology of the films was studied by 
SEM through a JEOL JSM 840A. 
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3. Result and Discussion
 
 




The UV-Visible spectrum of chitosan-
silver nanocomposite films is shown in 
Figure 1. The spectrum of chitosan-
silver nanocomposite films shows a 
single peak at maximum wavelength 
420 nm which confirmed the presence 
of silver; this peak arises due to surface 
plasmon resonance vibrations of silver 
atoms. The peak at maximum 
wavelength 230 nm shows the presence 
of chitosan. 
Figure 2 shows the X-ray diffraction 
pattern chitosan-silver nanocomposite 
films. Several distinct diffraction peaks 
at 2 values of 20.5, 21.0, 27.2, 36.8, 
42.8, 50.5, 60.2 and 67.7 (crystalline 
peaks) is attributed to the presence of 
silver while the non-crystalline part 
indicate the presence of Chitosan as 
shown on the chitosan-silver 
nanocomposite XRD pattern which 
confirmed the formation of the 
nanocomposite. 
 
Figure 3 shows the FTIR spectra of 
chitosan-silver nanocomposite films. 
The absorption peaks in the chitosan-






characteristic of O-H stretching and O-
H bending of chitosan respectively. The 
stronger the hydrogen bond the longer 
the O-H bond, the lower the vibration 
frequency, and the broader and the more 
intense the absorption band. The peak 
observed at 1619.29 cm
-1
indicates 
hydrogen bonding nature of N-H 
bending and the peak at 3369.75 cm
-1 
represents H bonded-OH of chitosan, 
the lower the frequency the stronger the 
H bond. The SEM image in Figure 4 
reveals rough surfaces with whitish 
particles (silver nanoparticles) 
surrounded with black particles 
(chitosan), a clear evidence of swelling 
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Figure 4: SEM image of chitosan-silver nanocomposite  film 
3.2 Swelling Test 
Swelling test is useful for correlating 
drug release characteristics from 
polymeric films and barriers. It can be 
judiciously used in predicting and 
modifying drug release from dosage 
forms. The cross-linked chitosan-silver 
nanocomposite is known to be 
dependent on the availability of the 
cationic sites and the negatively charged 
species. 
 
3.3 Release Study 
Phosphate buffer (pH 7.4) has been 
considered as release medium which 
simulates body fluid according to 
literatures. However, crosslinked 
chitosan-silver demonstrated a slower 
silver release pattern relative to un-
crosslinked chitosan-silver. Moreover, it 
was apparently noted from the graphs 
that almost all the silver nanoparticles 
within cross linked and uncross-linked 
became dislodged and completely 
released at 120 minutes and 90 minutes 
respectively. This result perfectly agrees 
with our swelling studies, where 
swelling property of cross-linked 
chitosan-silver exhibited onset of 
dormancy at 120 minutes which made it 
coincided with un-crosslinked chitosan- 
silver. From swelling and release 
studies, it is easy to explain that silver 
nanoparticles is gradually released into 
the system (according to figure 6 
below). This is a clear evidence that 
polymer composite like chitosan can 
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              Figure 5: Swelling ratio against time.     
  
 
                    Figure 6: Shows the release of Silver from Chitosan 
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Figure 7: Shows silver released pattern of crosslinked chitosan-silver film compared 
with un crosslinked chitosan-silver. 
 
 
Table 1: Antibacterial Activity of Films against test pathogens                                                   
Pathogens Zones of inhibition (mm) 
A (mg/ mL) B (mg/ mL) C (mg/mL) D (mg/mL) *Control 
100 50 25 100 50 25 100 50 25 100 50 25  
Staphylococcus 
aureus  
16 10 5 12 8 Nil 12 7 Nil 11 6 Nil 21 
Shigella sp. 15 10 6 11 5 10 11 5 Nil 8 Nil Nil 21 
Escherichia coli 10 5 Nil 9 4 Nil 8 4 Nil 7 Nil Nil 16 
Salmonella sp. 9 6 Nil 8 5 Nil 8 4 Nil 6 Nil Nil 19 
Klebsiella sp. 8 6 Nil 9 7 Nil 7 Nil Nil Nil Nil Nil 21 
 
*Control: Ciprofloxacin, Sample A: crosslinked chitosan- silver, Sample B:  un-crosslinked 
chitosan-silver, Sample C: crosslinked chitosan, Sample D: chitosan 
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The antibacterial activity of the 
synthesized nanocomposite films was 
evaluated by agar well diffusion 
method. The inhibitory growth was 
measured based on the diameter of the 
clear inhibition zone. The results of the 
antibacterial activity of the synthesized 
nanocomposite films are shown in Table 
1. With the exception of Chitosan, films 
at higher concentration (100mg/mL) 
showed higher antibacterial activity 
against Staphylococcus aureus, Shigella 
sp. Escherichia coli, Salmonella sp. and 
Klebsiella sp, but they were not as 
active as ciprofloxacin (control) which 
could be due to the concentrations used. 
The results further revealed that the 
higher the concentrations of the films, 
the higher their antibacterial activities 
against test pathogens. 
4. Conclusion 
In this study, Chitosan-silver 
nanocomposite films were synthesized 
by reduction method. Various 
characterisation techniques also 
confirmed the synthesis of chitosan-
silver nanocomposite films. Crosslinked 
chitosan-silver nanocomposite film 
showed a slow silver release pattern 
relative to the un-crosslinked 
nanocomposite. The synthesized 
nanocomposite demonstrated higher 
antibacterial activity at higher 
concentration against some pathogens. 
Thus, Chitosan-silver nanocomposite 
films can be useful in different 
biological research and biomedical 
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